The Latest Breaking News from diabetes

Diabetes patients could be offered weight loss jabs sooner in major shake-up

The changes will impact millions of people with type 2 diabetes in England in the biggest shake-up of care in a decade

The Independent UK · Aug 19, 2025

Type 2 diabetes patients set for major shake-up in care

New draft guidance from the National Institute for Health and Care Excellence suggests the NHS should move away from a one-size-fits-all approach.

The Independent UK · Aug 19, 2025

Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk

Health Canada on Tuesday approved Novo Nordisk's (NYSE:NVO) Ozempic (semaglutide) to reduce the risk of kidney disease and cardiovascular deaths in adults with type 2 diabetes.

Benzinga · Aug 19, 2025

Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst

On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom.

Benzinga · Aug 15, 2025

Mounjaro Is About to Get More Expensive in the UK: Here Are Cheaper Alternatives Available Right Now

Mounjaro's UK price will rise by 170% in September, prompting interest in cheaper alternatives like semaglutide for weight loss.

International Business Times UK · Aug 15, 2025

Ozempic didn’t work for me. I was furious – and ashamed

Everyone taking the ‘skinny shot’ was losing weight, but my scales didn’t change. My inner dialogue became toxic

The Guardian - US · Aug 14, 2025

Drug that slows onset of type 1 diabetes licensed for use in UK-first

The cost-effectiveness of the drug for NHS roll-out will now be assessed by the National Institute for Health and Care Excellence.

Evening Standard · Aug 14, 2025

Breakthrough drug that slows onset of type 1 diabetes set for UK release

Teplizumab can allow patients to live “normal lives” without the need for insulin injections

The Independent UK · Aug 14, 2025

Eli Lilly To Raise Mounjaro Price In UK, Expands Obesity Drug Push In India

Eli Lilly and Co. (NYSE:LLY) will sharply increase the list price of its weight-loss and type 2 diabetes drug Mounjaro (tirzepatide) in the United Kingdom, while expanding its market presence in India with a new injector pen.

Benzinga · Aug 14, 2025

Diabetic man produces his own insulin after gene-edited cell transplant

The new proof-of-concept study points a way to curing diabetes without the need for immune-suppressing drugs.

LiveScience · Aug 13, 2025